RESUMO
Globally, cancer patients frequently use T&CM during their treatment for various reasons. The primary concerns regarding the use of T&CM among cancer patients are the potential risks associated with interactions between pharmaceuticals and T&CM, as well as the risk of noncompliance with conventional cancer treatments. Despite the higher prevalence of T&CM use in Asia, driven by cultural, historical, and resource-related factors, no prior review has tried to estimate the prevalence and influencing factors of T&CM use and disclosure among cancer patients in this region. This study aims to examine the prevalence and disclosure rates of T&CM use among cancer patients in Asia to assess various factors influencing its use across different cancer treatment settings in Asia. Systematic research on T&CM use was conducted using four databases (PubMed, EMBASE, Web of Science, and CINAHAL) from inception to January 2023. Quality was assessed using the Appraisal Tool for Cross-Sectional Studies (AXIS). A random effects model was used to estimate the pooled prevalence of T&CM use, and data analysis was performed using Stata Version 16.0. Among the 4849 records retrieved, 41 eligible studies conducted in 14 Asian countries were included, involving a total of 14,976 participants. The pooled prevalence of T&CM use was 49.3%, ranging from 24.0% to 94.8%, and the disclosure rate of T&CM use was 38.2% (11.9% to 82.5%). The most commonly used T&CM modalities were herbal medicines and traditional medicine. Females were 22.0% more likely to use T&CM than males. A subgroup analysis revealed the highest prevalence of T&CM use was found in studies conducted in East Asia (62.4%) and those covered by both national and private insurance (55.8%). The disclosure rate of T&CM use to physicians remains low. Moreover, the factors influencing this disclosure are still insufficiently explored. Since the disclosure of T&CM use is a crucial indicator of patient safety and the quality of cancer treatment prognosis, future research should focus on identifying the determinants of non-disclosure.
RESUMO
Introduction: Surgical management of pelvic and acetabular fractures due to high-energy trauma is one of the most challenging in orthopaedics. Most patients are often associated with other life-threatening injuries. Several studies demonstrated that accurate fracture reduction decreases the incidence of post-traumatic arthritis and improves functional outcomes. The aim of the study was to find out the prevalence of the surgical management among patients with acetabular-pelvis fractures in a trauma care centre. Methods: This is a descriptive observational study conducted at a trauma hospital from 1 September 2016 to 31 August 2020. Ethical approval was obtained from the Institutional Review Committee. Patients with displaced fractures of the pelvis ring or acetabulum were included in the study whereas isolated pubic rami fractures and pathological fractures were excluded from the study. Operative plans were decided after radiographic X-rays and 3-dimensional reconstruction computed tomography scan evaluation. A convenience sampling method was used. The point estimate was calculated at a 95% Confidence Interval. Results: Among 136 patients with acetabular-pelvis fractures, 64 (47.06%) (38.67-55.45, 95% Confidence Interval) underwent surgical management. The average time duration from injury to surgery was 7 days. All patients were able to weight bear 3 months. Conclusions: The prevalence of surgical management among patients with pelvic-acetabular fracture was found to be similar to the other studies done in similar settings. Keywords: acetabulum; fracture fixation; pelvis.